22157.jpg
Insights on the Anticoagulants Global Market to 2025 - Rising Prevalence of Cardiovascular Disease is Driving Growth
September 22, 2021 08:28 ET | Research and Markets
Dublin, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025 Edition)" report has been added to...
22157.jpg
Insights on the $87+ Billion Cardiovascular Drugs Global Market to 2030 - Identify Growth Segments for Investment
May 17, 2021 04:38 ET | Research and Markets
Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
gmi logo.jpg
Anticoagulants Market revenue to cross USD 51.9 Bn by 2027: Global Market Insights Inc.
March 08, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Anticoagulants Market by Drug Class (Factor Xa Inhibitors, Heparin, Warfarin, Direct Thrombin Inhibitors),...
22157.jpg
Global and United States Anticoagulants Market Size & Forecast Report 2020-2024 with Impact Analysis of COVID-19
September 14, 2020 07:38 ET | Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to...
UCHealth is Colorado's first health system to implant new device to prevent strokes
February 23, 2016 11:08 ET | UCHealth
AURORA, Colo., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Heart specialists at UCHealth's Medical Center of the Rockies and University of Colorado Hospital are the first in the region to implant a new device...
Personalized Medicine: Genomics Helps BC Pharmacists Target the Right Drugs for the Right Patient VANCOUVER, BC--(Marketwired - October 28, 2014) - **Note to Editors** Both b-roll video and still photos are available. An exciting new research project that aims to make personalized medicine a...
On-X Life Technologies Inc. logo
On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
October 22, 2012 08:01 ET | On-X Life Technologies Inc.
If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
American Heart Association Logo
Clot-Busting Drug Safe for Stroke Patients Taking Blood Thinner
May 10, 2012 16:00 ET | American Heart Association
Highlights: It's safe to treat acute ischemic stroke patients who take the blood thinner warfarin with the clot-busting drug tissue plasminogen activator (tPA) when used according to American...
On-X Life Technologies Inc. logo
On-X Life Technologies Releases Expected Timelines for Reduced Anticoagulation Study Results at AATS
April 30, 2012 07:59 ET | On-X Life Technologies Inc.
SAN FRANCISCO, April 30, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is releasing the expected timelines for the initial submission to the FDA of...
American Heart Association Logo
Stroke Risk High When Anti-Clotting Drugs Stopped
April 25, 2012 13:00 ET | American Heart Association
Study Highlights: Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped. The risks are similar...